ImmunityBio Investors Alerted to Lead Plaintiff Deadline

Investors in ImmunityBio, Inc. (NASDAQ: IBRX) are being encouraged to contact Kaplan Fox before the lead plaintiff deadline on May 26, 2026, indicating a potential legal action or class-action lawsuit.

16 Apr, 14:30 — 16 Apr, 14:30

Post Share

Sources

Showing 1 of 1 sources

globe-and-mailHigh123d ago

IMMUNITYBIO DEADLINE: Investors of ImmunityBio, Inc. (NASDAQ: IBRX) are Encouraged to Contact Kaplan Fox Before the Lead Plaintiff Deadline on May 26, 2026 - The Globe and Mail

IMMUNITYBIO DEADLINE: Investors of ImmunityBio, Inc. (NASDAQ: IBRX) are Encouraged to Contact Kaplan Fox Before the Lead Plaintiff Deadline on May 26, 2026 The Globe and Mail

Read full article →

PERSPECTA

PERSPECTA

ImmunityBio Investors Alerted to Lead Plaintiff Deadline

Sources

IMMUNITYBIO DEADLINE: Investors of ImmunityBio, Inc. (NASDAQ: IBRX) are Encouraged to Contact Kaplan Fox Before the Lead Plaintiff Deadline on May 26, 2026 - The Globe and Mail

Related Stories

Cornerstone Funds Declare Monthly Dividends and Announce 2026/2027 Distributions

The OLB Group Reports Q2 Financials; FinVolution Group to Announce Results

Mark Cuban and Tech Founders Oppose California Wealth Tax Proposal

Greece to Save €2 Billion by Early Debt Repayment in 2026

PERSPECTA